MeSH Browser

MeSH Supplementary: tecovirimat
Unique ID: C505045
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C505045
Entry Term(s): 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop(f)isoindol-2(1H)-yl)-benzamide; N-((3aR,4R,4aR,5aS,6S,6aS)-1,3-Dioxo-3,3a,4,4a,5,5a,6,6a-octahydro-4,6-ethenocyclopropa(f)isoindol-2(1H)-yl)-4-(trifluoromethyl)benzamide; SIGA-246; ST 246; ST-246; TPOXX; benzamide, N-((3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop(F)isoindol-2(1H)-yl)-4-(trifluoromethyl)-, hydrate (1:1), rel-; tecovirimat monohydrate
Pharm Action: Antiviral Agents
Registry Numbers: F925RR824R; 0; SB96YO2BR8
Related Numbers: SB96YO2BR8
Heading Mapped to: *Benzamides; *Phthalimides
Frequency: 81
Note: A potent and specific inhibitor of orthopoxvirus replication. It is used for the treatment of SMALLPOX and other orthopoxvirus infections, including MONKEYPOX under expanded access investigational new drug protocol (https://www.cdc.gov/poxvirus/monkeypox/clinicians/Tecovirimat.html).
Source: J Virol 2005 Oct;79(20):13139-49
Date of Entry: 2005/11/02
Revision Date: 2022/08/05

tecovirimat MeSH Supplementary Concept Data 2025